Edesa Biotech is trading 5.1% down today at $4.85 as the stock continues a volatility-driven pullback noted late last week.
- The move appears to be a continuation of recent technical selling in a thinly traded biotech name, occurring even as broader markets trade higher.
- There are no fresh company press releases, SEC filings, clinical updates, or analyst calls today pointing to a new fundamental catalyst for the downward pressure.